Yoshinori Ikehata
Overview
Explore the profile of Yoshinori Ikehata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taniguchi T, Muraoka K, Nishikawa K, Ikehata Y, Setoguchi K, Oka S, et al.
Sci Rep
. 2024 Dec;
14(1):30986.
PMID: 39730921
Renorrhaphy is often performed after tumor resection during robotic-assisted laparoscopic partial nephrectomy (RAPN). This study aimed to investigate the association between renorrhaphy performance and inflammatory markers. A retrospective cohort study...
2.
Taniguchi K, Taniguchi T, Muraoka K, Nishikawa K, Ikehata Y, Setoguchi K, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518583
This study investigated the effect of mannitol administration on postoperative renal function during robot-assisted partial nephrectomy (RAPN) in patients with renal cell carcinoma (RCC). Patients with RCC who underwent RAPN...
3.
Yokoyama Y, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, et al.
Int Urol Nephrol
. 2024 Nov;
57(3):809-816.
PMID: 39516348
Purpose: The optimal neoadjuvant regimen before radical prostatectomy (RP) in patients with high-risk (HR) prostate cancer (PCa) remains to be determined. This retrospective multicenter cohort study assessed the effectiveness and...
4.
Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, et al.
World J Urol
. 2024 Mar;
42(1):152.
PMID: 38483586
Purpose: There are no definitive prognostic factors for patients with pathological Grade Group 5 (pGG 5) prostate cancer (PCa) undergoing robot-associated radical prostatectomy (RARP). This study aimed to explore the...
5.
Toide M, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, et al.
J Robot Surg
. 2024 Jan;
18(1):38.
PMID: 38231428
To investigate the incidence and risk factors of inguinal hernia (IH) after robot-assisted radical prostatectomy (RARP) using a multicentric database. The present study used a multicentric database (the MSUG94) containing...
6.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, et al.
Ann Surg Oncol
. 2024 Jan;
31(3):2154-2162.
PMID: 38200385
Objective: This study aimed to investigate whether lymphovascular invasion (LVI) was associated with oncological outcomes in patients with prostate cancer (PCa) undergoing robotic-assisted radical prostatectomy (RARP). Methods: This retrospective multicenter...
7.
Murase K, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, et al.
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137801
: We aimed to examine the relationship between the inflammation-related parameters, such as the neutrophil-to-lymphocyte ratio (NLR), and the pathological findings and biochemical recurrence (BCR) in patients with prostate cancer...
8.
Sakaguchi K, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, et al.
Int J Med Robot
. 2023 Nov;
:e2593.
PMID: 37984071
Background: The impact of unilateral and bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy (NS-RARP) procedures on continence and the time to continence recovery have not been established. Material And Methods: We...
9.
Kawase M, Goto T, Ebara S, Tatenuma T, Sasaki T, Ishihara T, et al.
Ann Surg Oncol
. 2023 Jun;
30(11):6925-6933.
PMID: 37338747
Purpose: We created a clinically applicable nomogram to predict locally advanced prostate cancer using preoperative parameters and performed external validation using an external independent validation cohort. Patients And Methods: From...
10.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, et al.
J Robot Surg
. 2023 Mar;
17(4):1609-1617.
PMID: 36928750
Locally advanced prostate cancer (PCa) with pathological seminal vesicle invasion (pT3b) is a very-high-risk disease associated with biochemical recurrence (BCR), local recurrence, distant metastases, or mortality following definitive therapies. This...